Wednesday, July 8, 2026

Drug profile · INN

cerivastatin sodium

cerivastatin sodium (BAYCOL) is a hmg-coa reductase inhibitor. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 11
Pipeline programs 14
News articles 0
Drug details — cerivastatin sodium
US status
approved
Class
Route
ORAL
Patents
11
Programs
14
Data quality
0.84

Quick answer

cerivastatin sodium (BAYCOL) is a hmg-coa reductase inhibitor. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN cerivastatin sodium
Brand BAYCOL
Mechanism HMG-CoA reductase inhibitor
Target 3-hydroxy-3-methylglutaryl-coenzyme A reductase
Route ORAL
Formulation TABLET

Mechanism of action

HMG-CoA reductase inhibitor

Primary target: 3-hydroxy-3-methylglutaryl-coenzyme A reductase

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. 19920 Phase 3 · Bayer · Proteinuria, Chronic kidney disease
  2. BAY 1841788, TRIPTORELIN Phase 3 · Ningbo Cancer Hospital · Patients with localised prostate cancer and high-risk featur
  3. BAY 3427080, BAY 3427080 60 mg capsules placebo Phase 3 · Bayer · Vasomotor symptoms caused by adjuvant endocrine therapy in w
  4. BAY 59-7939 Phase 3 · Bayer HealthCare Animal · Pulmonary Embolism
  5. D9723C00001 Phase 3 · AstraZeneca · Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
  6. P01351 Phase 3 · George Institute for · Chronic kidney disease
  7. 22040 Phase 2 · Bayer · Chronic kidney disease
  8. 22752 Phase 2 · Bayer · HER2 mutation, Advanced solid tumors

Related & competitor drugs

  1. atorvastatin calcium HMG-CoA reductase inhibitor
  2. fluvastatin sodium HMG-CoA reductase inhibitor
  3. lovastatin HMG-CoA reductase inhibitor
  4. pitavastatin calcium HMG-CoA reductase inhibitor
  5. rosuvastatin calcium HMG-CoA reductase inhibitor
  6. simvastatin HMG-CoA reductase inhibitor

Related patents

  1. CN 115003329

    Parapoxvirus for conditioning and treating coronavirus infections

    Expires Thu Aug 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. BR 112021015776

    Edição de gene para hemofilia a com expressão de fator viii melhorada

    Expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. DE 102019218587

    Kontrastmittelbasierte Gefäßdarstellung

    Expires Tue May 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 2020384125

    GENE EDITING FOR HEMOPHILIA A WITH IMPROVED FACTOR VIII EXPRESSION

    Expires Wed Dec 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. EP 3728594

    MATERIALIEN UND VERFAHREN ZUR BEHANDLUNG DES USHER-SYNDROMS TYP 2A

    Expires Tue Oct 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. CA 3121191

    CAS9 DE CODAGE D'ARNM OPTIMISE DESTINE A ETRE UTILISE DANS DES LNP

    Expires Wed May 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. CA 3118090

    COMPOSITIONS ET PROCEDES POUR EDITION DU GENOME A MEDIATION PAR NHEJ

    Expires Wed May 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. CA 3097885

    PROCEDES ET COMPOSITIONS D'EPUISEMENT DE LYMPHOCYTES T CYTOTOXIQUES

    Expires Wed Oct 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. CA 3079172

    COMPOSITIONS ET METHODES POUR L'EDITION GENIQUE POUR L'HEMOPHILIE A

    Expires Wed Apr 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. WO 2018227427

    DÉRIVÉS DE DIAZÉPANE PONTÉS SUBSTITUÉS ET LEUR UTILISATION

    Expires Wed Dec 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. WO 2018128828

    NOUVEAUX MIMÉTIQUES D'HEPCIDINE ET LEURS UTILISATIONS

    Expires Wed Jul 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is cerivastatin sodium?

cerivastatin sodium (BAYCOL) is a hmg-coa reductase inhibitor. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for cerivastatin sodium?

BAYCOL is a marketed brand name for cerivastatin sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of cerivastatin sodium?

cerivastatin sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.